NeoGenomics, a provider of cancer-focused genetic testing services and global oncology contract research services, agreed to acquire Intervention Insights (dba Trapelo Health), a clinical decision

NeoGenomics, a provider of cancer-focused genetic testing services and global oncology contract research services, agreed to acquire Intervention Insights (dba Trapelo Health), a clinical decision